Amyloidosis Progress
Diagnosis, treatment and research: how the care of cardiac amyloidosis has evolved over recent decades, based on a review of three parallel advances.
Newsroom
June 2023
-
-
Amyloidosis and physical activity
Amyloidosis can affect the heart, kidneys and nerves. Why regular physical activity adapted to each person can play a useful role alongside treatment.
-
Cardiac amyloidosis is under-diagnosed
Cardiac amyloidosis often goes unrecognised, even by doctors. What it is, a case seen in an emergency department, and why earlier diagnosis matters.
-
The WHF forum in Switzerland
At a World Heart Federation forum in Geneva in May 2023, patient representatives, including for ATTR cardiomyopathy, spoke about rare heart diseases.
-
Clinical trial accessible to everybody
Plain language summaries of key ATTR amyloidosis clinical trial publications are now available in seven languages, to make results accessible to patients.